A Glycine‐Targeted In Vivo Magnetic Resonance Spectroscopy for Quantifying Glycine in Glioma

ABSTRACT Background Glycine (Gly) is a key metabolic intermediate in the proliferation of tumor cells. Monitoring the concentration of Gly in tumor tissues is of great importance for understanding the growth status of tumors. At present, magnetic resonance spectroscopy (MRS) is the only method to no...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 62; no. 4; pp. 1219 - 1229
Main Authors Huang, Kai, Hao, Xiao‐Zhu, Fu, Cai‐Xia, Yang, Zhong, Ren, Yan, Yang, Xue, Zhang, Shi‐Ji, Zhu, Mei‐Lin, Yao, Zhen‐Wei, Wei, Da‐Xiu, Yao, Ye‐Feng
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.10.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1053-1807
1522-2586
1522-2586
DOI10.1002/jmri.29824

Cover

More Information
Summary:ABSTRACT Background Glycine (Gly) is a key metabolic intermediate in the proliferation of tumor cells. Monitoring the concentration of Gly in tumor tissues is of great importance for understanding the growth status of tumors. At present, magnetic resonance spectroscopy (MRS) is the only method to non‐invasively measure Gly concentration in human tissues. However, in conventional MR spectra the 1H signal of Gly overlaps with those of other molecules. This makes conventional MRS difficult to accurately measure the Gly concentration in human tissues. Purpose To develop a pulse sequence, Gly‐MRS, which can accurately measure Gly concentrations without the influence of the signal overlapping from other molecules in subjects with glioma. Study Type Prospective. Subjects/Phantoms A phantom of the glycine (Gly), myo‐inositol (MI) and glutamate (Glu) mixture aqueous solution and 6 phantoms of Gly aqueous solution (pH = 7.2 ± 0.1), 6 subjects with glioma (3 females and 3 males, BMI: 20 ± 4 kg/m2, age: 50 ± 10 years). Field Strength/Sequence 3 Tesla/A Gly‐targeted magnetic resonance spectroscopy pulse sequence, Gly‐MRS, using Point‐RESolved Spectroscopy (PRESS) for single voxel signal selection. Assessment By applying the developed pulse sequences to the phantoms and the subjects with glioma, the Gly 1H signals were successfully selectively probed. Quantification of the signals yields the concentrations of Gly in the regions of the tumor tissues of the subjects with glioma. Statistical Tests Numerical data only. Results The Gly 1H signals were detected in the tumor regions of 6 subjects with glioma, at a mean concentration of 5.20 mM (standard deviation, ± 3.29 mM). One subject exhibited a clear spatial distribution in the Gly concentrations in the tumor regions. Data Conclusion The Gly‐MRS pulse sequence developed in this work might be useful for the accurate in vivo detection of the 1H signal of Gly in gliomas of human beings. Evidence Level 2. Technical Efficacy Stage 3.
Bibliography:This work was supported by the National Key R&D Program of China (Grant No. 2023YFF1204801) and Shanghai Municipal Science and Technology Commission (Grant No. YDZX20243100003001001). Prof. Yan Ren acknowledges support from Natural Science Foundation of Shanghai (Grant No. 24ZR1408500).
Funding
Kai Huang and Xiao‐Zhu Hao are co‐first authors. They have contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1053-1807
1522-2586
1522-2586
DOI:10.1002/jmri.29824